105 related articles for article (PubMed ID: 7494857)
1. Interferon-alpha hybrids.
Horisberger MA; Di Marco S
Pharmacol Ther; 1995 Jun; 66(3):507-34. PubMed ID: 7494857
[TBL] [Abstract][Full Text] [Related]
2. Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.
Platis D; Foster GR
J Interferon Cytokine Res; 2003 Nov; 23(11):655-66. PubMed ID: 14651780
[TBL] [Abstract][Full Text] [Related]
3. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a single amino acid substitution at position 79 of human IFN-α2b in interferon-receptor assembly and activity.
Talebi S; Saeedinia A; Zeinoddini M; Ahmadpour F; Sadeghizadeh M
Prep Biochem Biotechnol; 2019; 49(8):735-743. PubMed ID: 31135267
[TBL] [Abstract][Full Text] [Related]
5. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
6. Binding and activity of all human alpha interferon subtypes.
Lavoie TB; Kalie E; Crisafulli-Cabatu S; Abramovich R; DiGioia G; Moolchan K; Pestka S; Schreiber G
Cytokine; 2011 Nov; 56(2):282-9. PubMed ID: 21856167
[TBL] [Abstract][Full Text] [Related]
7. Homology model of human interferon-alpha 8 and its receptor complex.
Seto MH; Harkins RN; Adler M; Whitlow M; Church WB; Croze E
Protein Sci; 1995 Apr; 4(4):655-70. PubMed ID: 7613464
[TBL] [Abstract][Full Text] [Related]
8. Domains of interaction between alpha interferon and its receptor components.
Uzé G; Di Marco S; Mouchel-Vielh E; Monneron D; Bandu MT; Horisberger MA; Dorques A; Lutfalla G; Mogensen KE
J Mol Biol; 1994 Oct; 243(2):245-57. PubMed ID: 7932753
[TBL] [Abstract][Full Text] [Related]
9. Human IFN-alpha protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity.
Hu R; Bekisz J; Schmeisser H; McPhie P; Zoon K
J Immunol; 2001 Aug; 167(3):1482-9. PubMed ID: 11466368
[TBL] [Abstract][Full Text] [Related]
10. Interferons alpha/beta and their receptors: place in the hierarchy of cytokines.
Zav'Yalov VP; Zav'Yalova GA
APMIS; 1997 Mar; 105(3):161-86. PubMed ID: 9137512
[TBL] [Abstract][Full Text] [Related]
11. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
12. Differences in activity between alpha and beta type I interferons explored by mutational analysis.
Runkel L; Pfeffer L; Lewerenz M; Monneron D; Yang CH; Murti A; Pellegrini S; Goelz S; Uzé G; Mogensen K
J Biol Chem; 1998 Apr; 273(14):8003-8. PubMed ID: 9525899
[TBL] [Abstract][Full Text] [Related]
13. Protein engineering of interferon alphas.
Hu R; Lei KJ; Bekisz J; Zoon KC
Methods Mol Med; 2005; 116():69-80. PubMed ID: 16000855
[TBL] [Abstract][Full Text] [Related]
14. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras.
Goldman LA; Cutrone EC; Dang A; Hao X; Lim JK; Langer JA
Biochemistry; 1998 Sep; 37(37):13003-10. PubMed ID: 9737881
[TBL] [Abstract][Full Text] [Related]
15. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
16. Bovine type I interferon receptor protein BoIFNAR-1 has high-affinity and broad specificity for human type I interferons.
Langer JA; Yang J; Carmillo P; Ling LE
FEBS Lett; 1998 Jan; 421(2):131-5. PubMed ID: 9468293
[TBL] [Abstract][Full Text] [Related]
17. Biological characterization of pegylated interferons: a case study.
Xie L; Cullen C; Bradshaw S; DeLorenzo M; Grace MJ
Methods Mol Biol; 2005; 308():319-35. PubMed ID: 16082045
[No Abstract] [Full Text] [Related]
18. Intrinsic ligand binding properties of the human and bovine alpha-interferon receptors.
Lim JK; Xiong J; Carrasco N; Langer JA
FEBS Lett; 1994 Aug; 350(2-3):281-6. PubMed ID: 8070579
[TBL] [Abstract][Full Text] [Related]
19. [Relation between structure and anti-viral activity in interferon system].
Sugiyama K; Voss T; Ahorn H; Maurer-Fogy I; Barsoumian EL
Yakugaku Zasshi; 1995 May; 115(5):390-3. PubMed ID: 7595866
[TBL] [Abstract][Full Text] [Related]
20. Biologic activities of natural and synthetic type I interferons.
Pfeffer LM
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
